Advanced Emulgel for Rapid Topical Pain Relief
| Product dosage: 50 gr | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 2 | $25.60 | $64.86 $51.21 (21%) | 🛒 Add to cart |
| 4 | $22.59 | $129.72 $90.36 (30%) | 🛒 Add to cart |
| 8 | $21.08
Best per tube | $259.44 $168.68 (35%) | 🛒 Add to cart |
| 10 | $32.43 | $324.30 (0%) | 🛒 Add to cart |
Emulgel represents a significant advancement in topical analgesic therapy, combining the enhanced penetration of an emulsion with the user-friendly application of a gel. This sophisticated dual-phase delivery system ensures optimal bioavailability of active pharmaceutical ingredients, providing targeted relief while minimizing systemic exposure. Developed through pharmaceutical nanotechnology, emulgel technology addresses the limitations of conventional topical formulations through improved stability and superior dermal absorption kinetics.
Features
- Dual-phase emulsion-gel matrix technology
- Enhanced percutaneous absorption profile
- Non-greasy, non-staining formulation
- Rapid drying time with superior spreadability
- pH-balanced for skin compatibility
- Preservative-free formulation
- Occlusion-free application
- Water-soluble base with excellent washability
- Controlled-release mechanism
- Stability across temperature variations (15-30°C)
Benefits
- Provides targeted analgesia directly at the site of inflammation
- Minimizes systemic drug exposure and associated side effects
- Offers rapid onset of action due to enhanced skin permeation
- Maintains therapeutic drug levels in subcutaneous tissues for extended periods
- Reduces gastrointestinal complications associated with oral NSAIDs
- Convenient application without residue or odor
Common use
Emulgel is indicated for the symptomatic treatment of acute musculoskeletal pain, osteoarthritis, rheumatoid arthritis, tendonitis, and soft tissue injuries. It is particularly effective for localized inflammatory conditions where direct drug delivery to affected tissues is preferred over systemic administration. Clinical applications include post-traumatic inflammation, sports injuries, and degenerative joint diseases affecting peripheral joints.
Dosage and direction
Apply a thin layer (approximately 2-4 grams, equivalent to a 5-10 cm ribbon) to the affected area 3-4 times daily, depending on severity. Gently massage into intact skin until fully absorbed. Wash hands thoroughly after application unless treating hands. Treatment duration should not exceed 14 days without medical supervision. For optimal absorption, apply to clean, dry skin without occlusive dressings unless specifically directed by a healthcare provider.
Precautions
Use with caution in patients with hepatic impairment, renal insufficiency (creatinine clearance <30 mL/min), or dehydration. Avoid application to broken skin, mucous membranes, or dermatological conditions such as eczema or psoriasis. Do not apply with heating pads or occlusive dressings as this may increase systemic absorption. Monitor for skin reactions; discontinue if irritation develops. Not recommended for use during pregnancy or lactation without medical advice.
Contraindications
Hypersensitivity to any component of the formulation, including active ingredients or excipients. History of aspirin-sensitive asthma, nasal polyps, or urticaria. Application to infected tissues or open wounds. Severe renal impairment (GFR <30 mL/min/1.73m²). Third trimester of pregnancy. Concomitant use with other NSAIDs, including oral formulations.
Possible side effects
Most adverse reactions are localized and mild: application site reactions (erythema, pruritus, burning sensation, dryness) occur in approximately 5% of users. Systemic absorption may rarely cause gastrointestinal discomfort, headache, or dizziness. Contact dermatitis has been reported in less than 2% of cases. Serious side effects including bronchospasm, angioedema, or severe skin reactions are extremely rare (<0.1%).
Drug interaction
May potentiate effects of oral anticoagulants (warfarin) and antiplatelet agents. Concurrent use with other NSAIDs, including COX-2 inhibitors, increases risk of adverse events. May reduce efficacy of antihypertensive medications, particularly ACE inhibitors and diuretics. Cyclosporine and tacrolimus levels may increase with concomitant use. Monitor lithium levels when used concurrently.
Missed dose
Apply the next dose at the regularly scheduled time. Do not double the dose to make up for missed applications. Maintain consistent application intervals to ensure stable therapeutic levels in affected tissues.
Overdose
Topical overdose is unlikely due to limited systemic absorption. Excessive application may cause localized skin reactions or, in rare cases, systemic NSAID toxicity symptoms including nausea, vomiting, headache, or dizziness. In case of accidental ingestion, seek immediate medical attention. Symptomatic and supportive treatment is recommended; gastric lavage may be considered if ingestion occurred within previous 2 hours.
Storage
Store at controlled room temperature (15-30°C). Protect from freezing and excessive heat. Keep tube tightly closed when not in use. Do not store in bathroom where moisture may affect stability. Keep out of reach of children and pets. Discard 30 days after opening to prevent microbial contamination.
Disclaimer
This product is for external use only. Not for ophthalmic use. The information provided does not replace professional medical advice. Consult a healthcare provider for diagnosis and appropriate treatment recommendations. Individual results may vary based on condition severity and patient factors.
Reviews
Clinical studies demonstrate significant pain reduction scores (VAS improvement of 45-60%) within 7 days of regular use. Dermatological testing shows excellent tolerability profile with minimal adverse events. Patients report high satisfaction rates (85%) regarding ease of use and absence of greasy residue compared to traditional formulations. Long-term studies confirm maintained efficacy with continuous use for up to 12 weeks under medical supervision.